Antibody Response to COVID-19 Vaccines in Liver Disease Patients

Clinical trial NCT04775069 · COMPLETED

Trial details

NCT number: NCT04775069
Sponsor: Humanity & Health Medical Group Limited
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Liver Disease

Start date: 2021-05-21
Primary completion: 2023-09-30
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.